FDA Approves Nasal Spray Med For Depression

Credit: Wochit News
Published on March 6, 2019 - Duration: 00:35s

FDA Approves Nasal Spray Med For Depression

UPI reports Food and Drug Administration has approved a prescription-only nasal spray to treat depression -- marking the first medical advancement in fighting the affliction in more than 30 years.

The agency approved Johnson & Johnson's Spravato, which will carry the FDA's strongest box warning due to abuse potential.

FDA Dr.

Advertisement

FDA Approves Nasal Spray Med For Depression

OCT.

14, 2015, FILE PHOTO AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDIT

You are here

Recent related videos from verified sources

FDA approves first generic naloxone nasal spray to treat opioid overdose 00:26
Credit: FOX 47 News Michigan - Published on April 22, 2019 

FDA Approves Generic Equivalent To Opioid Overdose Med Naloxone 00:34
Credit: Wochit - Published on April 20, 2019 

You might like